Literature DB >> 12578941

Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages.

K S Wong1, Y L Chan, J Y Liu, S Gao, W W M Lam.   

Abstract

The authors measured the presence and extent of asymptomatic microbleeds on gradient-recalled-echo MRI in 21 aspirin users who developed intracerebral hemorrhage and 21 aspirin users without history of intracerebral hemorrhage. Microbleeds were more frequent (19 vs 7, p < 0.001) and more extensive (mean number of microbleeds 13.3 vs 0.4, p < 0.001) in the intracerebral hemorrhage group than in the control group. Asymptomatic microbleeds may be a risk factor for aspirin-associated intracerebral hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12578941     DOI: 10.1212/01.wnl.0000046583.40125.20

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

1.  Lobar cerebral microbleeds associated with transient focal neurological symptoms followed by symptomatic intracerebral hemorrhage.

Authors:  Bang-Hoon Cho; Joon-Tae Kim; Suk-Hee Heo; Jane Chang; Kang-Ho Choi; Tai-Seung Nam; Seung-Han Lee; Seong-Min Choi; Man-Seok Park; Ki-Hyun Cho
Journal:  J Neurol       Date:  2012-04-26       Impact factor: 4.849

Review 2.  Update on intracerebral haemorrhage.

Authors:  José M Ferro
Journal:  J Neurol       Date:  2006-05-06       Impact factor: 4.849

3.  Association between carotid artery plaque type and cerebral microbleeds.

Authors:  L Saba; R Montisci; E Raz; R Sanfilippo; J S Suri; M Piga
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-24       Impact factor: 3.825

Review 4.  Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk Updated meta-analysis.

Authors:  Andreas Charidimou; Ashkan Shoamanesh; Duncan Wilson; Qiang Gang; Zoe Fox; H Rolf Jäger; Oscar R Benavente; David J Werring
Journal:  Neurology       Date:  2015-09-15       Impact factor: 9.910

5.  Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy.

Authors:  A Biffi; A Halpin; A Towfighi; A Gilson; K Busl; N Rost; E E Smith; M S Greenberg; J Rosand; A Viswanathan
Journal:  Neurology       Date:  2010-08-24       Impact factor: 9.910

6.  Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation.

Authors:  Mark H Eckman; Daniel E Singer; Jonathan Rosand; Steven M Greenberg
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-12-07

7.  A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates.

Authors:  Yuko Izuhara; Nagahisa Yamaoka; Hidehiko Kodama; Takashi Dan; Shunya Takizawa; Noriaki Hirayama; Kanji Meguro; Charles van Ypersele de Strihou; Toshio Miyata
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

Review 8.  Aspirin resistance and other aspirin-related concerns.

Authors:  Gaoyu Cai; Weijun Zhou; Ya Lu; Peili Chen; Zhongjiao Lu; Yi Fu
Journal:  Neurol Sci       Date:  2015-11-14       Impact factor: 3.307

9.  Frequency of asymptomatic microbleeds on T2*-weighted MR images of patients with recurrent stroke: association with combination of stroke subtypes and leukoaraiosis.

Authors:  Hiromitsu Naka; Eiichi Nomura; Shinichi Wakabayashi; Hiroshi Kajikawa; Tatsuo Kohriyama; Yasuyo Mimori; Shigenobu Nakamura; Masayasu Matsumoto
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

10.  Association between cerebral microbleeds on T2*-weighted MR images and recurrent hemorrhagic stroke in patients treated with warfarin following ischemic stroke.

Authors:  H Ueno; H Naka; T Ohshita; K Kondo; E Nomura; T Ohtsuki; T Kohriyama; S Wakabayashi; M Matsumoto
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-22       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.